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BCL2 (18q21) PAC 248E24 - Courtesy Mariano Rocchi. 
Description 
Telomere to centromere orientation; 3 exons; exon 1 
and the 3' part of exon 3 are non coding. 
Transcription 
2 alternative transcripts (a and b); 5.1 kb mRNA; 
coding sequence: CDS 1459...2178. 
Protein 
Description 
25 kDa; 205 amino acids (BCL2b) or 239 amino acids 
(BCL2a, which has, in addition, a hydrophobic tail for
membrane anchorage; this tail seems necessary for anti 
apoptotic ability); contain homo/heterodimerization 
domains (BH) and NH domains. 
Expression 
Wide; in B and T cells in particular. 
Localisation 
Mainly in the mitochondrial membrane; other 
membranes. 
Function 
Antiapoptosis, through a possibly complex process;  
dimerization, especially with BAX; role of the BCL2 
anti-apoptosis members in forming complexes with 
caspase-9 and APAF1 (homolog of the nematode CED-
4), which prevent them to initiate the protease cascade 
(through caspase-3 cytochrome C dependent activation 
and) leading to apoptosis. 
Homology 
With Ced9 (nematode C. elegans); with other member 
of the BCL2 family: 1- apoptosis inhibitors BCLX, 
MCL1, and 2- apoptosis inducers BAX, BAD, BIK, …
Implicated in 
t(14;18)(q32;q21)/B-cell malignancies 
→ IgH - BCL2 
Disease 
B-cell NHL mainly; found in 80 to 90% of follicular 
lymphomas, 30% of diffuse large cell lymphomas. 
Prognosis 
According to the cyto-pathologic subtype: small 
cleaved cell follicular lymphomas have a good 
prognosis; large cell lymphomas have a worse 
prognosis; the t(14;18) may have no prognostic 
significance. 
Cytogenetics 
Complex karyotypes are frequent with +7, del(6q), 
+12, + X, … 
Hybrid/Mutated Gene 
5' BCL2 translocated on chromosome 14 near JH 
(junctions genes of IgH) and C in 3'. 
Abnormal Protein 
No fusion protein, but promoter exchange; the 
immunoglobulin gene enhancer stimulates the 
expression of BCL2. 
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Oncogenesis 
As BCL2 is an apoptosis inhibitor, cell death is 
delayed, and there is cell accumulation (more than re l 
transformation). 
Chronic lymphocytic leukaemia 
Oncogenesis 
BCL2 is hypomethylated in the promotor region, and, 
therefore, overexpressed. 
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